Zhejiang Dayang Biotech Group Co (003017) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥638.25K ≈ $93.40K USD) by net assets (CN¥1.10 Billion ≈ $161.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 003017 net asset quality index to measure how much of total assets are equity-financed.

Zhejiang Dayang Biotech Group Co - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhejiang Dayang Biotech Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Zhejiang Dayang Biotech Group Co's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Dayang Biotech Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Deva Holding AS IS:DEVA	0.058x
Qingdao Victall Railway Co Ltd SHG:605001	-0.076x
SOLiD Inc KQ:050890	-0.030x
Guangdong Jushen Logistics Co Ltd SHE:001202	-0.042x
Precious Shipping Public Company Limited BK:PSL-R	0.038x
Oponeo.pl SA WAR:OPN	-0.042x
Seah Holdings KO:058650	-0.012x
Nalwa Sons Investments Limited NSE:NSIL	0.003x

Annual Cash Flow Conversion Efficiency for Zhejiang Dayang Biotech Group Co (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Dayang Biotech Group Co (003017) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.14 Billion ≈ $166.34 Million	CN¥160.11 Million ≈ $23.43 Million	0.141x	+124.09%
2024-12-31	CN¥1.05 Billion ≈ $154.11 Million	CN¥66.19 Million ≈ $9.69 Million	0.063x	-65.26%
2023-12-31	CN¥1.01 Billion ≈ $147.53 Million	CN¥182.42 Million ≈ $26.69 Million	0.181x	+93.97%
2022-12-31	CN¥985.05 Million ≈ $144.14 Million	CN¥91.89 Million ≈ $13.45 Million	0.093x	+362.87%
2021-12-31	CN¥990.71 Million ≈ $144.97 Million	CN¥-35.16 Million ≈ $-5.14 Million	-0.035x	-130.23%
2020-12-31	CN¥958.13 Million ≈ $140.20 Million	CN¥112.49 Million ≈ $16.46 Million	0.117x	-48.29%
2019-12-31	CN¥498.09 Million ≈ $72.89 Million	CN¥113.09 Million ≈ $16.55 Million	0.227x	+158.02%
2018-12-31	CN¥440.62 Million ≈ $64.48 Million	CN¥38.77 Million ≈ $5.67 Million	0.088x	-38.90%
2017-12-31	CN¥337.71 Million ≈ $49.42 Million	CN¥48.64 Million ≈ $7.12 Million	0.144x	-60.97%
2016-12-31	CN¥229.35 Million ≈ $33.56 Million	CN¥84.63 Million ≈ $12.38 Million	0.369x	+58.13%
2015-12-31	CN¥209.76 Million ≈ $30.70 Million	CN¥48.95 Million ≈ $7.16 Million	0.233x	-20.42%
2014-12-31	CN¥196.87 Million ≈ $28.81 Million	CN¥57.73 Million ≈ $8.45 Million	0.293x	-40.03%
2013-12-31	CN¥187.42 Million ≈ $27.43 Million	CN¥91.64 Million ≈ $13.41 Million	0.489x	--

About Zhejiang Dayang Biotech Group Co

SHE:003017 China Chemicals

Market Cap

$312.56 Million

CN¥2.14 Billion CNY

Market Cap Rank

#14531 Global

#4313 in China

Share Price

CN¥21.19

Change (1 day)

+2.66%

52-Week Range

CN¥19.40 - CN¥36.52

All Time High

CN¥39.37